Showing 11-20 of 71 Results
Assistant Professor of Chemical Engineering
BioDanielle J. Mai joined the Department of Chemical Engineering at Stanford in January 2020. She earned her B.S.E. in Chemical Engineering from the University of Michigan and her M.S. and Ph.D. in Chemical Engineering from the University of Illinois at Urbana-Champaign under the guidance of Prof. Charles M. Schroeder. Danielle was an Arnold O. Beckman Postdoctoral Fellow in Prof. Bradley D. Olsen's group at MIT, where she engineered materials with selective biomolecular transport properties, elucidated mechanisms of toughness and extensibility in entangled associative hydrogels, and developed high-throughput methods for the discovery of polypeptide materials. The Mai Research Group integrates precise biopolymer engineering with multiscale experimental characterization to advance biomaterials development and to enhance fundamental understanding of soft matter physics.
Ravindra Majeti MD, PhD
Professor of Medicine (Hematology)
Current Research and Scholarly InterestsThe Majeti lab focuses on the molecular/genomic characterization and therapeutic targeting of leukemia stem cells in human hematologic malignancies, particularly acute myeloid leukemia (AML). Our lab uses experimental hematology methods, stem cell assays, genome editing, and bioinformatics to define and investigate drivers of leukemia stem cell behavior. As part of these studies, we have led the development and application of robust xenotransplantation assays for human hematopoietic cells.
Assistant Professor of Pediatrics (Hematology/Oncology) at the Stanford University Medical Center
BioRobbie Majzner is an Assistant Professor of Pediatrics in the Division of Hematology and Oncology. After graduating with a BA from Columbia University, Dr. Majzner attended Harvard Medical School, where he developed an interest in pediatric oncology. He completed his residency training in pediatrics at New York Presbyterian-Columbia and fellowship training in pediatric hematology-oncology at Johns Hopkins and the National Cancer Institute. During his fellowship, he cared for some of the first pediatric patients to receive CD19 chimeric antigen receptor (CAR) T cells, children with B cell acute lymphoblastic leukemia (B-ALL) who often had no other therapeutic option. Witnessing the success of CAR T cells in these patients drove Dr. Majzner to the laboratory, where he focuses on extending the use of CAR T cells to solid tumors. He has generated and optimized novel receptors to recognize antigens over-expressed on pediatric solid tumors such as GD2 (Mount/Majzner et al., Nature Medicine, 2018) B7-H3 (Majzner et al., Clinical Cancer Research, 2019), and ALK (Walker/Majzner et al., Molecular Therapy, 2017). Current work focuses on imparting multi-specificity to CAR T cells and optimizing these receptors to enhance their efficacy when the amount of target (antigen density) is limiting (Majzner et al., ASH 2018). By drawing on state of the art bioengineering techniques, the Majzner Laboratory focuses on enhancing the potency and specificity of CAR T cells for children with cancer.
Clinically, Dr. Majzner cares for all patients with neuroblastoma at the Lucile Packard Children's Hospital and has a specific interest in bringing novel immunotherapies to clinical trials for these patients and those with other solid tumors. He is board certified in pediatrics and pediatric hematology-oncology.
Senior Associate Dean, Faculty Development and Diversity, Professor of Pediatrics (Infectious Diseases) and of Health Research and Policy
Current Research and Scholarly InterestsMy research focuses on epidemiologic aspects of viral vaccines and perinatal HIV infection. This includes the molecular epidemiology of factors affecting the immunogenicity of oral polio vaccine (OPV) in developing areas of the world, and now the epidemiology of transmission and circulation of vaccine derived polioviruses in order to assist in global eradication of polio. I also work in development of methods to prevent breastfeeding transmission of HIV in Africa.
Nancy Friend Pritzker Professor in Psychiatry and Behavioral Sciences
Current Research and Scholarly InterestsLong-lasting changes in synaptic strength are important for the modification of neural circuits by experience. A major goal of my laboratory is to elucidate the molecular events that trigger various forms of synaptic plasticity and the modifications in synaptic proteins that are responsible for the changes in synaptic efficacy.
Associate Professor (Research) of Radiation Oncology (Radiation and Cancer Biology), of Radiology (Molecular Imaging Program at Stanford) and, by courtesy, of Medicine (Oncology)
Current Research and Scholarly InterestsMy research interests focus on the design and discovery of synthetic, and natural product inspired small molecules which can be used as probes for developing understanding of biological phenomena, including protein-protein interactions and modulation of signal transduction pathways. My laboratory employs the tools of synthetic medicinal chemistry, molecular modeling and chemical biology for translational research in drug discovery, development, imaging and radiation.
Associate Professor (Research) of Radiology (Cancer Early Detection-Canary Center)
Current Research and Scholarly InterestsThe Mallick Lab is focused on using integrative, multi-omic approaches to model the processes that govern cellular dynamics and to use those models to discover cancer biomarkers and molecular mechanisms.
Edward Manche, MD
Professor of Ophthalmology at Stanford University Medical Center
BioEdward E. Manche, MD is Professor of Ophthalmology and Director of the Cornea and Refractive Surgery Service at Stanford University School of Medicine. He received his medical degree from Albert Einstein College of Medicine and completed residency training at the University of Medicine and Dentistry at New Jersey where he served as Chief Resident. He completed a two-year fellowship in Cornea and Refractive Surgery at the Jules Stein Eye Institute at UCLA.
Dr. Manche is a fellow of the American Academy of Ophthalmology and received its Achievement Award in 2003 and its Senior Achievement Award in 2014. He was elected to active membership in the American Ophthalmological Society in 2011, and is recognized in Best Doctors in America and Guide to America's Top Physicians. He serves on the editorial boards of the American Journal of Ophthalmology, Journal of Ophthalmology, Clinical and Experimental Ophthalmology and Journal of Refractive Surgery.
He lectures widely on topics in cornea and refractive surgery and has published over 115 peer-reviewed articles and 25 book chapters.
Thomas M. Siebel Professor in Machine Learning, Professor of Linguistics and of Computer Science
BioChristopher Manning is a professor of computer science and linguistics at Stanford University, Director of the Stanford Artificial Intelligence Laboratory, and Co-director of the Stanford Human-Centered Artificial Intelligence Institute. He works on software that can intelligently process, understand, and generate human language material. He is a leader in applying Deep Learning to Natural Language Processing, including exploring Tree Recursive Neural Networks, neural network dependency parsing, the GloVe model of word vectors, neural machine translation, question answering, and deep language understanding. He also focuses on computational linguistic approaches to parsing, natural language inference and multilingual language processing, including being a principal developer of Stanford Dependencies and Universal Dependencies. Manning is an ACM Fellow, a AAAI Fellow, an ACL Fellow, and a Past President of ACL. He has coauthored leading textbooks on statistical natural language processing and information retrieval. He is the founder of the Stanford NLP group (@stanfordnlp) and manages development of the Stanford CoreNLP software.
M. Peter Marinkovich, MD
Associate Professor of Dermatology
Current Research and Scholarly InterestsThe Marinkovich lab studies the function of epithelial extracellular matrix molecules, including integrins, collagens and laminins in epithelial development and carcinoma progression. We apply our discoveries in this area towards development of molecular therapies for carcinomas, hair disease and inherited epithelial adhesive disorders.